Strengthening the immune response to cancer
For patients with lymphoma, multiple myeloma, or certain types of leukemia, treatment with chimeric antigen receptor T cells (CAR T cells) is sometimes the last chance of overcoming the cancer. The treatment involves taking T cells from the patient’s blood and adding artificial receptors—the CARs—to them in the lab. As the guards of our immune system, T cells are on […]
Continue reading »